STAA Q1 2021 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$860M

Q1 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$51M+44.2% YoY

Gross Profit

$39M77.1% margin

Operating Income

$7M14.7% margin

Net Income

$5M9.8% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+10.3%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$5M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$266M

Total Liabilities

$52M

Stockholders' Equity

$214M

Cash & Equivalents

$162M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$51M	$35M	+44.2%
Gross Profit	$39M	$25M	+58.1%
Operating Income	$7M	-$1M	+758.1%
Net Income	$5M	-$134,000	+3825.4%

Revenue Segments

Implantable Collamer Lenses

$47M92%

Intraocular Lenses

$4M7%

Other Surgical Products

$526,0001%